Hum. Reprod. Advance Access originally published online on December 15, 2006
Human Reproduction 2007 22(4):912-915; doi:10.1093/humrep/del473
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEW DEBATE |
The preconceptual contraception paradigm: obesity and infertility
Reproductive and Maternal Medicine, Division of Developmental Medicine, University of Glasgow, Glasgow, UK
1 To whom correspondence should be addressed at: Reproductive and Maternal Medicine, Division of Developmental Medicine, University of Glasgow, Glasgow Royal Infirmary, 3rd Floor, Queen Elizabeth Building, 10 Alexandra Parade, Glasgow G31 2ER, UK. Tel: +44 141 211 4706; Fax: +44 141 552 0873; E-mail: s.nelson{at}clinmed.gla.ac.uk
Obesity is a major health problem across the world. Recent editorials suggest that obese patients should be denied treatment of any kind aimed to improve ovulation rates and achieve pregnancy until they have reduced their BMI. We propose that this approach is not a resolution of the problem, but indeed may amplify the maternal and perinatal complications attributed to fertility centres. Obesity independent of polycystic ovary syndrome (PCOS) is associated with anovulation, and minimal weight loss alone is an effective therapy for induction of ovulation in both obese women and obese PCOS women. Consequently, lifestyle programmes encouraging weight loss should be considered to be an ovulation induction therapy and due consideration for a potential pregnancy in an obese woman given. We propose that women with a BMI in excess of 35 kg m2 should lose weight prior to conceptionnot prior to receiving infertility treatment. Therefore, clinicians undertaking the management of infertility in obese women should adopt measures to reduce their body mass prior to exposing them to the risks of pregnancy. We advocate that this approach should be aggressively managed including pharmacological strategies; intrinsic in this programme is the use of contraception and high-dose folic acid during that period of preconceptual weight reduction.
Key words: infertility/pregnancy outcomes/obesity/contraception
Submitted on September 8, 2006; resubmitted on October 16, 2006; accepted on October 20, 2006.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. E. Minge, B. D. Bennett, R. J. Norman, and R. L. Robker Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone Reverses the Adverse Effects of Diet-Induced Obesity on Oocyte Quality Endocrinology, May 1, 2008; 149(5): 2646 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Palomba, F. Giallauria, A. Falbo, T. Russo, R. Oppedisano, A. Tolino, A. Colao, C. Vigorito, F. Zullo, and F. Orio Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study Hum. Reprod., March 1, 2008; 23(3): 642 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Leese, R. G. Sturmey, C. G. Baumann, and T. G. McEvoy Embryo viability and metabolism: obeying the quiet rules Hum. Reprod., December 1, 2007; 22(12): 3047 - 3050. [Abstract] [Full Text] [PDF] |
||||

